1. Academic Validation
  2. Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer

Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer

  • Cell Death Dis. 2022 Aug 29;13(8):748. doi: 10.1038/s41419-022-05169-x.
Ya-Fang Wang 1 2 Lei Yu 3 4 Zong-Long Hu 3 Yan-Fen Fang 3 Yan-Yan Shen 3 Min-Fang Song 5 Yi Chen 6 7
Affiliations

Affiliations

  • 1 Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PR China. [email protected].
  • 2 Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, PR China. [email protected].
  • 3 Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PR China.
  • 4 University of Chinese Academy of Sciences, Beijing, China.
  • 5 School of Life Science and Technology, ShanghaiTech University, Shanghai, PR China.
  • 6 Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, PR China. [email protected].
  • 7 University of Chinese Academy of Sciences, Beijing, China. [email protected].
Abstract

Tumor associated macrophages (TAMs) play an important role in tumorigenesis, development and anti-cancer drug therapy. However, very few epigenetic compounds have been elucidated to affect tumor growth by educating TAMs in the tumor microenvironment (TME). Herein, we identified that EZH2 performs a crucial role in the regulation of TAMs infiltration and protumoral polarization by interacting with human breast Cancer (BC) cells. We showed that EZH2 inhibitors-treated BC cells induced M2 macrophage polarization in vitro and in vivo, while EZH2 knockdown exhibited the opposite effect. Mechanistically, inhibition of EZH2 Histone Methyltransferase alone by EZH2 inhibitors in breast Cancer cells could reduce the enrichment of H3K27me3 on CCL2 gene promoter, elevate CCL2 transcription and secretion, contributing to the induction of M2 macrophage polarization and recruitment in TME, which reveal a potential explanation behind the frustrating results of EZH2 inhibitors against breast Cancer. On the contrary, EZH2 depletion led to DNA demethylation and subsequent upregulation of miR-124-3p level, which inhibited its target CCL2 expression in the tumor cells, causing arrest of TAMs M2 polarization. Taken together, these data suggested that EZH2 can exert opposite regulatory effects on TAMs polarization through its enzymatic or non-enzymatic activities. Our results also imply that the effect of antitumor drugs on TAMs may affect its therapeutic efficacy, and the combined application with TAMs modifiers should be warranted to achieve great clinical success.

Figures
Products